We're pleased to announce that Pharmica has joined ProPharma Group.

Together we are forming the world's leading provider of regulatory, clinical, and compliance services supporting clients throughout the full product lifecycle. Learn about our expanded services.

Resource Management: To Algorithm or Not to Algorithm?

Demand forecasting—the ability to project demand by role and project—is an important part of resource management. Companies conduct demand forecasting in several ways. Some have project managers enter demand by role for, say, 12 months. Others communicate standards to help drive consistency in how project managers estimate demand. Still, others create demand forecasting algorithms to[…]

Pharma: Not Everyone is a Project Manager But Everyone Manages Projects

The other day, a client asked me to define “project management.” I defined it broadly as the organization and management of work in an effective and useful manner. Based on that definition, I asserted that everyone in the pharmaceutical industry is a project manager. And I suggested that the more important question is not what project management[…]

Clinical Systems Vendor Selection – Six Things You Need to Do!

  The systems used in clinical R&D (or commercial, or HR, or finance…), like everything else in the world, eventually grow old and stop working the way we’d like them to. Fortunately, these systems can be replaced – though not necessarily any more cheaply or easily than your Uncle Irwin’s hip. Done the right way,[…]

Clinical Operations Process Improvement (Part II The Ultimate Metric)

There has been a big push recently to execute on more and more improvement projects.  This is thanks in part to the application of lean sigma for clinical operations. But, the financial benefits of an improvement project are not easy to figure out. For example, many such projects, and the metrics surrounding them, revolve around cycle-time[…]

Improving Clinical Operations Metrics (Part 1 – Metrics That Matter)

In the pharmaceutical industry, costs are becoming an increasingly scrutinized component of the clinical development process.  Companies are looking to increase profits by getting drugs to market faster. They are trying to bolster margins by conducting trials with the fewer and fewer resources.  Along these lines, many clinical operations groups are collecting clinical trial metrics as fast as they[…]